On Friday, the American Academy of Sleep Medicine (AASM) announced on its Web site that the Sleep Center at St. Lukes Medical Center Kirby Glen in Houston, Tex, has just become its 1,000th accredited facility.
Energy drinks that contain sugar and caffeine are a popular remedy for drowsiness, but new research shows that some such drinks may actually make a tired person feel worse.
More sleep medicine technicians are taking and passing the exam to become registered polysomnographic technologists (RPSGTs), said the Board of Registered Polysomnographic Technicians (BRPT), which administers the exam.
One New York state teenager was killed and another injured when a man with sleep apnea fell asleep behind the wheel of his Hummer and hit the girls, Suffolk County, NY, police said in a story reported in Newsday.
A new University of Florida study shows lack of sleep not only makes people tired and irritable but also causes them to dislike and even hate their jobs the next morning.
Based on a request from the Food and Drug Administration (FDA), Somaxon Pharmaceuticals, San Diego, is updating information regarding the preclinical testing of SILENOR™, a drug candidate for the treatment of insomnia.
An article reported in Japan’s Corporate News (JCN) lays out the results of a Tokiwa Pharmaceutical survey on sleep and lifestyle.
Findings from a recently conducted Bank of America survey, show that Respironics Inc, Murrysville, Pa, is geared up to assume leadership in the sleep therapeutic market, the Associated Press reports.
A new study of AMBIEN CR, a controlled-release formula prescription sleep medication approved by the Food and Drug Administration (FDA) for sleep maintenance and sleep induction, found that the drug demonstrated significant improvements in total sleep time (TST), sleep onset latency (SOL), wake time after sleep onset (WASO), sleep quality, and number of awakenings versus placebo.
Physicians who treat insomnia may soon find their patients asking for a new medication. After a year of marketing the insomnia medication Rozerem to physicians, the drug maker Takeda Pharmaceuticals North America, Lincolnshire, Ill, is taking its message direct to consumers with an advertising campaign launching today.